Trial Profile
A Phase Ib Study of Oral Selinexor in Adult Patients With Relapsed/Refractory B-cell Lymphoma Receiving R-DHAOx or R-GDP
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jan 2023
Price :
$35
*
At a glance
- Drugs Selinexor (Primary) ; Cisplatin; Cytarabine; Dexamethasone; Gemcitabine; Oxaliplatin; Rituximab
- Indications B-cell lymphoma; Diffuse large B cell lymphoma; Follicular lymphoma; Marginal zone B-cell lymphoma
- Focus Adverse reactions
- Acronyms SELINDA
- 13 Dec 2022 Final results (n=18) presented at the 64th American Society of Hematology Annual Meeting and Exposition.
- 14 Dec 2021 Results presented at the 63rd American Society of Hematology Annual Meeting and Exposition
- 06 Dec 2021 Status changed from active, no longer recruiting to completed.